Recombinant Mouse Tripartite motif-containing protein 43C (Trim43c)

What is Trim43c and how does it relate to other Trim43 proteins in mice?

Trim43c is one of three related genes (alongside Trim43a and Trim43b) expressed specifically during preimplantation stages of mouse embryonic development. These three genes share high sequence similarity at both nucleotide (97% identity between transcripts) and protein levels (92-95% identity). At the protein level, Trim43c shares 92% identity with Trim43a and 94% identity with Trim43b, while Trim43a and Trim43b share 95% identity . All three genes are confirmed to be distinct genes in the mouse genome as verified by Southern blot analysis, despite their high sequence similarity .

What is the expression pattern of Trim43c during mouse embryonic development?

Trim43c expression is highly stage-specific, being restricted to preimplantation embryonic stages with peak expression observed at the 8-cell to morula stage. Among the three Trim43 genes, Trim43c shows the lowest expression level, with Trim43b being the most highly expressed followed by Trim43a in morula-stage embryos. Expression analysis using sequence chromatography of PCR-amplified cDNA from morula-stage embryos confirms the presence of transcripts from all three genes, albeit at different levels .

How can Trim43c be detected in preimplantation embryos?

Trim43c can be detected through several methods:

• Quantitative RT-PCR (qRT-PCR) using specific primers that can distinguish between the three Trim43 variants

• Sequence analysis of PCR products amplified from cDNA mixtures of embryos, examining sequence chromatographs for multiple nucleotide peaks at positions where the three variants differ

• Southern blot analysis to confirm the presence of the gene in the genome

• Promoter-reporter constructs using fluorescent proteins (such as Emerald or mStrawberry) can be used to visualize expression patterns in live embryos

What promoter constructs are available for studying Trim43 gene expression in preimplantation embryos?

Several promoter constructs have been developed and validated for studying Trim43 expression patterns:

• pTrim43a(ATG)-Emerald-3′UTR: Contains a 5 kb DNA fragment covering the region from ATG codon to 5 kb upstream of the ATG codon of Trim43a gene (containing the first and second exons), fused to Emerald fluorescent protein and the 3′UTR of Trim43 gene with polyA signal

• pTrim43a(ATG)-mStrawberry-3′UTR: Similar to the above but using mStrawberry (red) fluorescent protein

• pTrim43a(ATG)-Emerald-tkPolyA: Uses HSV tk polyA instead of the Trim43 3′UTR

• pTrim43a(1stExon)-Emerald-3′UTR: Contains the 5 kb upstream region from the first exon, not the ATG codon

These constructs can be microinjected into pronuclei of 1-cell embryos to monitor expression patterns. Fluorescent signals typically become detectable by the late 2-cell stage and dramatically increase in later stages, peaking at the morula stage, which matches the endogenous expression pattern of Trim43 genes .

What approaches can be used to downregulate Trim43c expression in research models?

Attempts to suppress Trim43 transcript levels using siRNA technology have been reported, though with limited success. Researchers have tried:

• Injecting a mixture of four oligonucleotide siRNAs into 1-cell mouse embryos at various concentrations (5, 10, and 20 μM)

• Injecting siRNA mixtures into both blastomeres of 2-cell embryos

These approaches have not resulted in significant downregulation of Trim43 expression. The challenge may be related to the dilution of siRNAs as embryos cleave, combined with the very high expression levels of Trim43 genes by the morula stage . Alternative approaches that might be considered include:

• CRISPR/Cas9-mediated genome editing to knock out Trim43c

• Morpholino antisense oligonucleotides, which may have longer half-lives than siRNAs

• Using inducible promoter systems to express shRNAs targeting Trim43 transcripts

How can researchers distinguish between the three Trim43 variants in experimental systems?

Distinguishing between the three highly similar Trim43 variants requires specific methodological approaches:

• Sequence-specific PCR primers designed to target unique regions where the three variants differ

• Sequencing of PCR products and analysis of chromatographs to identify variant-specific nucleotide positions

• Quantitative analysis of sequence peak heights at positions of variation to estimate relative abundance of each transcript

• Copy-specific antibodies, if available, targeting unique epitopes in each protein variant

• Variant-specific promoter constructs to study individual gene regulation

When analyzing sequence chromatographs from cDNA mixtures, specific nucleotide positions can serve as signatures for each variant. For example, the presence of a "C" peak at position 2 in the chromatograph indicates Trim43a expression, peaks of "GAGT" at positions 62-65 indicate Trim43b, and a small "A" peak at position 53 indicates Trim43c expression .

What is known about the asymmetric expression of Trim43 genes in early embryos?

Asymmetric expression patterns have been observed for Trim43 genes in early embryos:

• Promoter-reporter constructs show asymmetric distribution of fluorescent signals beginning at the 2-cell stage

• qRT-PCR analysis of single blastomeres in 4-cell and 8-cell embryos shows variability in Trim43 transcript levels among blastomeres

• At the 4-cell stage, one or two blastomeres show much lower levels of Trim43 than other blastomeres

• At the 8-cell stage, in three of four embryos tested, two blastomeres showed much lower levels of Trim43 than other blastomeres

• Co-injection experiments with Trim43 promoter-Strawberry and Zscan4 promoter-Emerald constructs showed that asymmetric expression was specific to the Trim43 promoter

This asymmetric expression may be related to the presence of repetitive sequences in the Trim43 promoter region, potentially causing variegated expression. Addition of a chicken beta-globin 5′ HS4 insulator element at the 5′-end of the expression unit attenuated but did not completely eliminate this asymmetric expression .

How does the human ortholog of Trim43c compare to the mouse version?

Human TRIM43 shares approximately 41-42% protein sequence identity with mouse Trim43 proteins. Specifically:

• Human TRIM43 shares 42% identity with mouse TRIM43C (Trim43c)

• Human TRIM43 shares 41% identity with both mouse TRIM43A (Trim43a) and TRIM43B (Trim43b)

• The domain sequences show high conservation in specific regions: RING (48.7%), Bbox (54.7%), and SPRY (50%) domains between human TRIM43 and mouse TRIM43A proteins

Human TRIM43 is mapped to Chromosome 2, while the top human protein hits for mouse Trim43 include TRIM43, TRIM17-like protein, and TRIM11 (36% identity, mapped to Chromosome 11) .

What primer designs are effective for qRT-PCR analysis of Trim43c expression?

For effective qRT-PCR analysis of Trim43c expression, researchers should consider the following approach:

• Design primer pairs using specialized software (e.g., Vector NTI)

• Test primers using ovary cDNA with SYBR Green PCR Master Mix

• Dilute cDNAs obtained from oocytes and embryos with the Ovation kit to 1:25 in a total of 1000 μl and use 2 μl as template

• Normalize data using housekeeping genes such as Chuk with the ΔΔCt method

• For distinguishing between Trim43 copies, synthesize cDNA from pooled embryos (approximately 10) at the 8-cell stage using primers amplifying the entire CDS

• Analyze sequence chromatographs for signature nucleotide positions that differ between variants

Primer selection is critical due to the high sequence similarity between the three Trim43 genes. For specific detection of Trim43c, primers should target regions containing unique nucleotide differences between the variants.

What methodological challenges exist in studying the specific function of Trim43c?

Several methodological challenges exist when studying Trim43c specifically:

• High sequence similarity (97% at nucleotide level) between the three Trim43 genes makes selective targeting difficult

• The transient and stage-specific expression pattern limits the window for experimental manipulation

• Conventional knockdown approaches using siRNAs have proven ineffective, possibly due to:

  • Dilution of siRNAs during rapid embryonic cleavage

  • Extremely high expression levels during peak periods

  • Potential functional redundancy between the three variants

• The presence of repetitive sequences in the promoter region can cause variegated expression in reporter systems

• Embryo-to-embryo variation in transcript levels complicates the interpretation of expression analysis results

To overcome these challenges, researchers might consider:

• CRISPR/Cas9-mediated knockout strategies

• Conditional knockout systems to control timing of gene silencing

• Triple knockout of all three Trim43 genes followed by selective rescue experiments

• Advanced single-cell RNA sequencing to better characterize expression patterns

What potential roles might Trim43c play in preimplantation development?

Based on its expression pattern and characteristics, several potential roles for Trim43c in preimplantation development can be hypothesized:

• Stage-specific regulation of protein degradation via its RING finger domain (potentially functioning as an E3 ubiquitin ligase)

• Transcriptional regulation during the critical 8-cell to morula transition

• Involvement in embryonic genome activation or maternal transcript clearance

• Potential role in early cell fate decisions, suggested by its asymmetric expression pattern

• Contribution to protein quality control during the stress of rapid cell divisions

Future research should focus on identifying interaction partners and substrates of Trim43c, as well as investigating the phenotypic consequences of its targeted deletion or overexpression.

How might the variegated expression of Trim43 genes contribute to early developmental processes?

The observed asymmetric expression of Trim43 genes in early embryos raises interesting questions about their potential developmental roles:

• The variegation could contribute to early cell fate specification or lineage determination

• Asymmetric protein distribution might lead to differential protein degradation pathways in different blastomeres

• The observed pattern might relate to epigenetic mechanisms establishing developmental heterogeneity

• The variegation could be involved in regulating the timing of embryonic genome activation in different blastomeres

• The asymmetric expression might relate to the first cellular differentiation events in mammalian development

Research exploring the correlation between Trim43 expression patterns and subsequent cell fate or developmental potential would provide valuable insights into these possibilities.

What are the optimal conditions for recombinant expression of mouse Trim43c protein?

While the provided search results don't specifically address recombinant expression of Trim43c, general considerations for expressing TRIM family proteins would include:

• Expression system selection:

  • Mammalian expression systems (HEK293, CHO cells) might better preserve proper folding and post-translational modifications

  • Insect cell systems (Sf9, Hi5) could provide improved yields for structural studies

  • Bacterial systems might be suitable for domain-specific studies but may face solubility challenges

• Construct design considerations:

  • Including appropriate affinity tags (His, FLAG, GST) for purification

  • Codon optimization for the chosen expression system

  • Considering full-length versus specific domain expression

  • Potentially including the native 3′UTR if it contains regulatory elements

• Purification strategy:

  • Multiple chromatography steps likely required for high purity

  • Buffer conditions that maintain protein stability and prevent aggregation

  • Testing for proper folding and activity post-purification

What control experiments should be included when studying the promoter activity of Trim43c?

Based on the methodologies described in the literature, several important control experiments should be included when studying Trim43c promoter activity:

• Comparison with promoter constructs from other Trim43 variants (Trim43a, Trim43b)

• Co-injection of different promoter constructs driving different fluorescent proteins (e.g., Trim43-Strawberry and control promoter-Emerald) to validate specificity

• Inclusion of insulator elements to assess the impact of position effects and variegation

• Testing of truncated promoter constructs to identify minimal regions required for stage-specific expression

• qRT-PCR validation of endogenous gene expression patterns for comparison with reporter activity

• Control promoters with constitutive or alternative stage-specific expression patterns

• Analysis of multiple independent embryos to account for embryo-to-embryo variation

These control experiments help distinguish promoter-specific effects from technical artifacts and provide confidence in the interpretations of expression patterns.